{"id":"W4388019704","doi":"10.1136/jitc-2023-007047","title":"Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomized phase III IMpower010 trial","year":2023,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"Genentech; F. Hoffmann-La Roche","keywords":"Atezolizumab; Medicine; Concordance; Internal medicine; Lung cancer; Adjuvant; Immunohistochemistry; Oncology; PD-L1; Cancer; Immunotherapy; Pembrolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008278642,0.001258977,0.002162802,0.0004884639,0.0002386165,0.001406167,0.001007333,0.001284664,0.001528401],"category_scores_gemma":[0.005360392,0.0006717005,0.001916108,0.0004021054,0.001053187,0.0008171031,0.0004616149,0.002687904,0.0003243678],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001091199,"about_ca_system_score_gemma":0.0009130364,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003905614,"about_ca_topic_score_gemma":0.0008041767,"domain_scores_codex":[0.9967813,0.002069715,0.000166585,0.0003628845,0.0004531936,0.0001662902],"domain_scores_gemma":[0.9954561,0.00171835,0.001481717,0.0004413189,0.0003040265,0.0005984723],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9206333,0.004300188,0.02098302,0.0005203311,0.002056001,0.00004087444,0.0001053962,0.001050442,0.01350195,0.0001480239,0.0009688298,0.03569156],"study_design_scores_gemma":[0.5559992,0.3391517,0.08583803,0.0001296388,0.003572359,0.0003767145,0.0000825367,0.004692034,0.007666844,0.0003787155,0.00202138,0.00009102792],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930836,0.003948857,0.0006178834,0.0002437638,0.00008108867,0.0005658629,0.0005888444,0.00004527844,0.000824839],"genre_scores_gemma":[0.9952165,0.0007337324,0.0009557991,0.0004027583,0.0001221986,0.0007198818,0.00139927,0.00002499258,0.0004248387],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008278642,"threshold_uncertainty_score":0.04378217,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05075007968482245,"score_gpt":0.4501255369726118,"score_spread":0.3993754572877893,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}